Alpha 2.0
Login Register
» Authors » Sara Brucker

Sara Brucker

Explore the profile of Sara Brucker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 1684
Followers 0
Related Specialties
Gynecology & Obstetrics
Oncology
Reproductive Medicine
Top 10 Co-Authors
Diethelm Wallwiener
Markus Wallwiener
Stefan Kommoss
Katharina Rall
Felix Neis
Florin-Andrei Taran
Tanja Fehm
Bernhard Kramer
Annette Staebler
Matthias W Beckmann
Published In
Geburtshilfe Frauenheilkd
Arch Gynecol Obstet
Fertil Steril
Psychother Psychosom Med Psychol
Gynecol Surg
Affiliations
Soon will be listed here.
Recent Articles
1.
Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy
Salker M, Liu A, Ruetalo N, Raja Xavier J, Lankapalli A, Raja Xavier J, et al.
Clin Sci (Lond) . 2024 Dec; 139(4). PMID: 39666439
Vertical transmission of SARS-CoV-2 during human pregnancy remains highly controversial as most studies have focused on the third trimester or the peripartum period. Given the lack of early trimester data,...
2.
Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability - Real-World Data from German Breast Centers
Schaffler H, Jakob D, Huesmann S, Pfister K, Veselinovic K, Schochter F, et al.
Geburtshilfe Frauenheilkd . 2024 Sep; 84(9):855-865. PMID: 39229630
Introduction: The third-generation antibody-drug conjugates (ADC), trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG), recently obtained approval for metastatic breast cancer treatment across various subtypes and therapeutic contexts. Materials And Methods:...
3.
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
Morice P, Scambia G, Abu-Rustum N, Acien M, Arena A, Brucker S, et al.
Lancet Oncol . 2024 Aug; 25(11):e602-e610. PMID: 39216500
The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on...
4.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer
Tempfer C, Fehm T, Vordermark D, Marnitz-Schulze S, Beckmann M, Denschlag D, et al.
Geburtshilfe Frauenheilkd . 2024 Jun; 84(6):523-528. PMID: 38884027
The presentation of the results of the prospective randomized international multicenter GCIG INTERLACE trial at the 2023 congress of the European Society of Medical Oncology (ESMO) is likely to change...
5.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer
Tempfer C, Brucker S, Juhasz-Boess I, Mallmann P, Steiner E, Denschlag D, et al.
Geburtshilfe Frauenheilkd . 2024 Jan; 83(9):1095-1101. PMID: 38230409
The publication of two large randomized studies - the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial and the NRG-GY018 trial - which investigated combining chemotherapy with immunotherapy to treat patients with primary advanced or recurrent...
6.
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced...
Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich B, Kurbacher C, et al.
Eur J Cancer . 2023 Dec; 198:113480. PMID: 38154393
Background: In MONALEESA-2, addition of ribociclib to letrozole resulted in significantly longer progression-free survival (PFS) in postmenopausal women with HR+HER2- advanced breast cancer (ABC). RIBociclib for the treatment of advanCed...
7.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Surgical Therapy for Patients with Stage IA2-IIB1 Cervical Cancer
Fehm T, Beckmann M, Mahner S, Denschlag D, Brucker S, Hillemanns P, et al.
Geburtshilfe Frauenheilkd . 2023 Oct; 83(10):1199-1204. PMID: 37808259
The presentation of the results of the prospective randomized international multicenter study AGO-OP.8 - CCTG CX.5 - SHAPE at the annual conference of the American Society of Clinical Oncology (ASCO)...
8.
Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center
Taran F, Pasternak J, Staebler A, Rohner A, Neis F, Engler T, et al.
Cancers (Basel) . 2023 Aug; 15(16). PMID: 37627138
Background: The aim of this study was to evaluate the impact of pathological tumor-free margin distance on survival in SCC patients treated with surgery alone. Methods: This retrospective study included...
9.
Improvement in Fertility and Pain after Endometriosis Resection and Adhesion Prevention with 4DryField PH: Follow-up of a Randomized Controlled Clinical Trial
Kramer B, Andress J, Neis F, Hoffmann S, Brucker S, Kommoss S, et al.
J Clin Med . 2023 May; 12(10). PMID: 37240703
Background: Adhesions after endometriosis resection are frequent and the most common causes for chronic pain and secondary infertility. Primary results of our randomized controlled trial (RCT) on adhesion prevention after...
10.
Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
Bae G, Berezhnoy G, Koch A, Cannet C, Schafer H, Kommoss S, et al.
Front Mol Biosci . 2023 May; 10:1158330. PMID: 37168255
Traditional diagnosis is based on histology or clinical-stage classification which provides no information on tumor metabolism and inflammation, which, however, are both hallmarks of cancer and are directly associated with...